Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-081715

Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 20,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-14 Exercise or conversion : show line 1 in the form +20,834 81,701 D
2023-07-14 Shares withheld for taxes : show line 2 in the form −8,851 $7.76 $68,684 72,850 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −20,834 125,007 D
Loading xslF345X05/tm2321428-3_4seq1.xml…